SCHEMBL29960283

SCHEMBL29960283

CC(C)(C)OC(=O)N1CCCC(=O)c2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.48
▸ NOTUM Q6P988 2/20 0.48
▸ HDAC1 Q13547 2/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.45
▸ LMNA P02545 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ BRD4 O60885 1/20 0.44
▸ BCHE P06276 1/20 0.43
▸ PDK4 Q16654 1/20 0.43
▸ MAPT P10636 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ UCHL1 P09936 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ BUB1 O43683 1/20 0.40
▸ SCN5A Q14524 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ SMARCA2 P51531 1/20 0.39
▸ SMARCA4 P51532 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14380662 1.00 KDM1A (0.48) KDM1ANOTUMHDAC1HDAC6LMNA
SCHEMBL641007 0.93 LMNA (0.51) KDM1ANOTUMHDAC1HDAC6LMNA
SCHEMBL29457581 0.93 LMNA (0.51) KDM1ANOTUMHDAC1HDAC6LMNA
SCHEMBL7004709 0.84 NOTUM (0.64) KDM1ANOTUMHDAC1HDAC6LMNA
SCHEMBL30667212 0.84 NOTUM (0.64) KDM1ANOTUMHDAC1HDAC6LMNA
SCHEMBL16359586 0.83 KDM1A (0.48) KDM1ANOTUMHDAC1HDAC6LMNA
SCHEMBL3127747 0.83 NOTUM (0.63) NOTUMHTTMAPTSMN1; SMN2MEN1
SCHEMBL29476005 0.83 NOTUM (0.63) NOTUMHTTMAPTSMN1; SMN2MEN1
SCHEMBL6341898 0.82 BRD4 (0.46) KDM1ABRD4PDK4UCHL1BUB1
SCHEMBL3531672 0.82 MEN1 (0.43) KDM1ANOTUMHDAC1HDAC6BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118791498-A Tetracyclic compound, preparation method thereof and application thereof in medicines 江苏恒瑞医药股份有限公司 2024-10-18 — — CN disclosed
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 — — WO disclosed
Send feedback